A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples